MedPath

Comparison of Misoprostol and Prostaglandin E2 (PGE2) Gel for Induction of Labour in Premature Rupture of Membranes at Term

Phase 4
Completed
Conditions
Premature Rupture of Membranes at Term
Interventions
Registration Number
NCT00355303
Lead Sponsor
Nilratan Sircar Medical College
Brief Summary

The purpose of this study is to determine whether induction of labor with vaginal misoprostol application will result in fewer cesarean deliveries than vaginal PGE2 gel application in women with premature rupture of membranes at term.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
932
Inclusion Criteria
  • Premature rupture of membranes at 37 or more weeks
  • Single live fetus in cephalic presentation
Exclusion Criteria
  • Women in labour
  • Women with contraindication of induction of labour
  • Women with previous caesarean section or uterine surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Misoprostol tablet, PGE2 gelPGE2 gelparticipants are assigned to one of two arms for the duration of the study In one group induction of labour is done by intravaginal misoprostol tablets at 4 hrly interval with maximum of five doses.In other group PGE2 gel is applied in poaterior fornix at six hourly interval.
Misoprostol tablet, PGE2 gelMisoprostolparticipants are assigned to one of two arms for the duration of the study In one group induction of labour is done by intravaginal misoprostol tablets at 4 hrly interval with maximum of five doses.In other group PGE2 gel is applied in poaterior fornix at six hourly interval.
Primary Outcome Measures
NameTimeMethod
Caesarean Section rate48 hours
Secondary Outcome Measures
NameTimeMethod
Induction delivery time48 hours
Neonatal & maternal infectious morbidity14 days following date of delivery

Trial Locations

Locations (1)

Nilratan Sircar Medical College, 138,AJC Bose Road,

🇮🇳

Kolkata, West Bengal, India

© Copyright 2025. All Rights Reserved by MedPath